Latest GST Update 2025: Impact on Pharma Sector and Medicines
The sweeping GST reforms (“GST 2.0”), which came into effect from 22 September 2025, have brought major changes to India’s indirect tax. One of the sectors most affected is pharmaceuticals (medicines, medical devices, diagnostics), and there are ripple effects across the supply chain—from raw material suppliers to manufacturers, distributors, pharmacies, and ultimately, patients. The GST … Continue reading Latest GST Update 2025: Impact on Pharma Sector and Medicines